drugset / Trial / NCT00230581
8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
RandomizedParallel-groupDouble-blindTreatment
Summary
In this study, female patients with IBS-d will be treated for 8 weeks to assess the safety and effectiveness of DDP225 on GI transit and in reducing IBS symptoms.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DDP225 | Small molecule | — | — |